Share: Title:CAPItello-292: capivasertib, palbociclib, and fulvestrant for HR+ endocrine-resistant breast cancer Duration: 1:29 Plays: 661 views Published: 3 years ago Download MP3 Download MP4 Simillar Videos ▶️ 0:34 Vjoncology At Btog 2023 661 views • 1 year ago ▶️ 0:47 Combining Radiotherapy With Novel Agents In Nsclc 661 views • 2 years ago ▶️ 2:52 Updated Overall Efficacy And Safety Of Selpercatinib In Patients With Ret Fusion+ Nsclc 661 views • 3 years ago ▶️ 1:21 Treating Patients With Bladder Cancer Who Won’t Undergo Radical Cystectomy 661 views • 8 months ago ▶️ 1:26 Hormone Receptor Status And Tumor Subtypes In Brca-variant Breast Cancer 661 views • 3 months ago